Curative Biotechnology, Inc.
CUBT
$0.0119
$0.00220.20%
OTC PK
| 03/31/2025 | 06/30/2022 | 03/31/2022 | 12/31/2021 | 09/30/2021 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -- | -- | 93.15% | 317.37% | -- |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -- | -- | -- | -96.92% | -- |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | -- | -- | -- | -64.63% | -- |
|
|
|||||
| Total Current Assets | -- | -- | -- | -64.63% | -- |
| Net Property, Plant & Equipment | -- | -- | -- | 191.30% | -- |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | 1,010.91% | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | -- | -- | -- | 6.07% | -- |
|
|
|||||
| Total Accounts Payable | -- | -- | -- | 643.25% | -- |
| Total Accrued Expenses | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -54.05% | -- |
| Total Other Current Liabilities | -- | -- | -- | -54.05% | -- |
| Total Current Liabilities | -- | -- | -- | 9.82% | -- |
|
|
|||||
| Total Current Liabilities | -- | -- | -- | 9.82% | -- |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | -- | -- | -- | 9.82% | -- |
|
|
|||||
| Common Stock & APIC | -- | -- | -- | 195.01% | -- |
| Retained Earnings | -- | -- | -- | -232.33% | -- |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | -- | -- | -269.11% | -261.85% | -- |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | 194.31% | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | 194.67% | 194.31% | -- |
|
|
|||||
| Total Common Equity | -- | -- | -269.11% | -261.85% | -- |
| Total Preferred Equity | -- | -- | 194.67% | 194.31% | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -- | -- | -14.52% | 4.52% | -- |
|
|
|||||